close read more

Our company

portrait Olivier LAUREAU


President of Servier

We are an international and independent pharmaceutical company governed by a non-profit foundation, with headquarters in Suresnes, France. Since opening our first laboratory in 1954, we have been committed to therapeutic progress to serve patient needs with the help of healthcare professionals. We strive to provide future generations with a world where quality healthcare is available and accessible to all.

Operating in 149 countries, we have 22,000 collaborators employed worldwide and a turnover of 4.176 billion euros in 2018. Entirely independent, we are able to reinvest 25% of our total revenue (excluding generics) into Research and Development, and all profits are used for further development.

Corporate growth at Servier is driven by our continuous pursuit of innovation in five areas of excellence: cardiovascular and immune-inflammatory diseases, neuropsychiatric disorders, cancer and diabetes. We are a leading force in cardiology—number 2 in Europe, number 5 worldwide—and oncology has become a top priority in recent years; we also manufacture high-quality generic drugs.

Our three research centres are continuously involved in creating, testing, and developing new medicinal products, which are manufactured and packaged in our 16 production centres around the world. 98% of Servier drugs active principles are synthesized in its own plant in Bolbec-Baclair in France. We have an active partnership policy in the field of biotechnology and we are investing in e-health through our internal WeHealth by Servier initiative.

All our employees are driven by shared values ​​and guided by a common vision. Together we share the passion of entrepreneurship and we are committed to therapeutic progress to serve patient needs.

With 100 million of patients treated worldwide by our medicinal products on a daily basis. we are keenly aware of our responsibilities to patients, doctors, and healthcare professionals. They are the motivating force behind our daily drive for innovation as a provider of therapeutic progress.

Our governance

We are an independent Group governed by a foundation, headed by a President and an Executive Committee.

See more

Our global presence

Our R&D, production, and subsidiary activities are carried out in nearly 70 countries worldwide and our medicines are available in 149 countries.

See more

Key figures

Our medicines are used to treat 100 million patients daily. 25% of our turnover, excluding generics, is reinvested in R&D.

See more

Our Story

Founded in 1954 by Jacques Servier in Orleans, France, our Group is now international and employs 22,000 people.

See more

Vocation and values

We are committed to therapeutic progress to serve patient needs.

See more

Our culture

The sustainability of our Group is based on innovation, sharing, commitment, and caring about others.

See more

Financial Results

Our 2018 turnover was 4.176 billion euros for two-thirds of our Servier medicines.

See more

Servier Institute

One of Servier's associations, its aim is to promote all forms of scientific knowledge thus contributing to medical progress, patient well-being and physician expectations.

See more